Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triple Therapy MRI in Asthma
NCT04651777Phase 3Active, not recruiting
- Sponsor
- Parraga Lab
- Start
- Aug 2022
- Primary completion
- Aug 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of fluticasone furoate + umeclidinium bromide + vilanterol trifenatate in asthma, sponsored by Parraga Lab. Started Aug 2022; status: active, not recruiting.
02
Drugs
fluticasone furoate + umeclidinium bromide + vilanterol trifenatate
03
Conditions
asthma
Beyond the preview
Go deeper on NCT04651777.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04651777.